86
Views
8
CrossRef citations to date
0
Altmetric
INVITED ARTICLE

HIV Treatment Adherence Research and Intervention

Current Advances and Future Challenges

&
Pages 9-22 | Published online: 22 Sep 2008

References

  • Ahdieh-Grant , L. , Silverberg , M. J. , Palacio , H. , Minkoff , H. , Anastos , K. Young , M. A. 2001 . Discontinuation of potent antiretroviral therapy: Predictive value of and impact on CD4 cell counts and HIV RNA levels . AIDS , 15 : 2101 – 2108 .
  • Ahdieh-Grant , L. , Tarwater , P. M. , Schneider , M. F. , Anastos , K. , Cohen , M. Khalsa , A. 2005 . Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study . Journal of Acquired Immune Deficiency Syndromes , 38 : 500 – 503 .
  • Ammassari , A. , Trotta , M. P. , Murri , R. , Castelli , F. , Narciso , P. Noto , P. 2002 . Correlates and predictors of adherence to highly active antiretro viral therapy: Overview of published literature . Journal of Acquired Immune Deficiency Syndromes , J7 : S123 – S127 .
  • Arnsten , J. H. , Demas , P. A. , Farzadegan , H. , Grant , R. W. , Gourevitch , M. N. Chang , C. J. 2001 . Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring . Clinical Infectious Diseases , 33 : 1417 – 1423 .
  • Bangsberg , D. R. 2006 . Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression . Clinical Infectious Diseases , 43 : 939 – 941 .
  • Bangsberg , D. R. , Hecht , F. M. , Charlebois , E. D. , Zolopa , A. R. , Holodniy , M. Sheiner , L. 2000 . Adherence to protease inhibitors, HrV-1 viral load, and development of drug resistance in an indigent population . AIDS , 14 : 357 – 366 .
  • Bangsberg , D. R. , Perry , S. , Charlebois , E. D. , Clark , R. A. , Robertson , M. Zolopa , A. R. 2001 . Non-adherence to highly active antiretroviral therapy predicts progression to AIDS . AIDS , 15 : 1181 – 1183 .
  • Bangsberg , D. R. , Simoni , J. , Ware , N. and Castro , A. 2006 . Developing theoretical models of adherence behavior in resource-limited settings . Paper presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . March 2006 , New Jersey, USA.
  • Behforouz , H. L. , Farmer , P. E. and Mukherjee , J. S. 2004 . From directly observed therapy to accompagnateurs: Enhancing AIDS treatment outcomes in Haiti and in Boston . Clinical Infectious Diseases , 3<5 ( Suppl. 5 ) : S429 – S436 .
  • Castilla , J. , del Romero , J. , Hernando , V. , Marincovich , B. , Garcia , S. and Rodriguez , C. 2005 . Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV . Journal of Acquired Immune Deficiency Syndromes , 40 : 96 – 101 .
  • Centers for Disease Control and Prevention . 2005 . Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services . Morbidity and Mortality Weekly Report , 54 ( RR-2 ) : 1 – 19 .
  • Crane , J. T. , Kawuma , A. , Oyugi , J. H. , Byakika , J. T. , Moss , A. Bourgois , P. 2006 . The price of adherence: Qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda . AIDS and Behavior , 10 : 437 – 442 .
  • Farmer , P. , Leandre , F. , Mukherjee , J. S. , Claude , M. S. , Nevil , P. Smith-Fawzi , M. C. 2001 . Community-based approaches to HIV treatment in resource-poor settings . Lancet , 358 : 404 – 409 .
  • Feaster , D. , Mitrani , V. B. , Prado , G. and Szapocznik , J. 2006 . Structural ecosystems therapy for improving HIV medication adherence in African American women. Paper presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . March 2006 , New Jersey, USA.
  • Fogarty , L. , Roter , D. , Larson , S. , Burke , J. , Gillespie , J. and Levy , R. 2002 . Patient adherence to HIV medication regimens: A review of published an abstract reports . Patient Education and Counseling , 46 : 93 – 108 .
  • Frick , P. , Tapia , K. , Grant , P. , Novotny , M. and Kerzee , J. 2006 . The effect of a multi-disciplinary program on HAART adherence . AIDS Patient Care and STDs , 20 : 511 – 524 .
  • Gandelman , A. and Rietmeijer , C. A. 2004 . Translation, adaptation, and synthesis of interventions for persons living with HIV: Lessons from previous HIV prevention interventions . Journal of Acquired Immune Deficiency Syndromes , J7 ( Suppl. 2 ) : S126 – S129 .
  • de Garcia , P. Olalla , Knobel , H. , Carmona , A. , Guelar , A. , Lopez-Colomes , J. L. and Cayla , J. A. 2002 . Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients . Journal of Acquired Immune Deficiency Syndromes , 30 : 105 – 110 .
  • Gardner , L. I. , Metsch , L. R. , Anderson-Mahoney , P. , Loughlin , A. M. , del Rio , C. Strathdee , S. 2005 . Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care . AIDS , 19 : 423 – 431 .
  • Gebo , K. A. , Fleishman , J. A. , Conviser , R. , Reilly , E. D. , Korthuis , P. T. Moore , R. D. 2004 . Racial and gender disparities in receipt of highly active antiretro viral therapy persist in a multistate sample of HIV patients in 2001 . Journal of Acquired Immune Deficiency Syndromes , 38 : 96 – 103 .
  • Giordano , T. P. , Visnegarwala , F. , White , A. C. , Troisi , C. L. , Frankowski , R. F. Hartman , C. M. 2005 . Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure . AIDS Care , 17 : 773 – 783 .
  • Golin , C. , Isasi , F. , Bontempi , J. B. and Eng , E. 2002 . Secret pills: HIV-positive patients' experiences taking antiretro viral therapy in North Carolina . AIDS Education and Prevention , 14 : 318 – 329 .
  • Gulick , R. M. 2006 . Adherence to antiretro viral therapy: How much is enough? . Clinical Infectious Diseases , 43 : 942 – 944 .
  • Hogg , R. S. , Heath , K. , Bangsberg , D. , Yip , B. , Press , N. O'Shaughnessey , M. V. 2002 . Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up . AIDS , 16 : 1051 – 1058 .
  • Janssen , R. S. , Holtgrave , D. R. , Valdiserri , R. O. , Shepherd , M. , Gayle , H. D. and De Cock , K. M. 2001 . The Serostatus Approach to Fighting the HIV Epidemic: Prevention strategies for infected individuals . American Journal of Public Health , 91 : 1019 – 1024 .
  • Kalichman , S. C. and Rompa , D. 2003 . HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy . Sexually Transmitted Infections , 79 : 59 – 61 .
  • Kayitenkore , K. , Bekan , B. , Rufagari , J. , Marion-Landais , S. , Karita , E. and Allen , S. 2006 . The impact of ART on HIV transmission among HIV serodiscordant couples ‘Abstract MOKC101’. Abstract published at the XVI International AIDS Conference, Toronto . August 2006 , Ontario, Canada.
  • Kidder , D. P. , Pals , S. L. , Wolitski , R. J. , Royal , S. , Stall , R. and the Housing and Health Study Team . 2006 . HIV medication use, adherence, and disclosure to family members are associated with viral load in homeless or unstably housed HIV positive persons ‘Abstract TUPE0755’. Abstract published at the XVI International AIDS Conference, Toronto . August 2006 , Ontario, Canada.
  • King , M. S. , Brun , S. C. and Kempf , D. J. 2005 . Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir . Journal of Infectious Diseases , 191 : 2046 – 2052 .
  • Koenig , S. P. , Leandre , F. and Farmer , P. E. 2004 . Scaling-up HIV treatment programmes in resource-limited settings: The rural Haiti experience . AIDS , 7<5 ( Suppl. 3 ) : S21 – S25 .
  • Kurth , A. 2006 . Antiretro viral adherence assessment. Paper presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . March 2006 , New Jersey, USA.
  • Liu , A. Y. , Grant , R. M. and Buchbinder , S. P. 2006 . Preexposure prophylaxis for HIV: Unproven promise and potential pitfalls . Journal of the American Medical Association , 296 : 863 – 865 .
  • Maggiolo , F. , Ravasio , L. , Ripamonti , D. , Gregis , G. , Quinzan , G. Arici , C. 2005 . Similar adherence rates favor different virologie outcomes for patients treated with nonnucleoside analogues or protease inhibitors . Clinical Infectious Diseases , 40 : 158 – 163 .
  • Mannheimer , S. B. , Botsko , M. , Hirschhorn , L. R. , Dougherty , J. , Celano , S. A. Ciccarone , D. 2006 . The CASE adherence index: A novel method for measuring adherence to antiretro viral therapy. Paper presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . 2006 , New Jersey, USA.
  • Mitchell , C. G. , Freels , S. , Creticos , C. M. and Douglas , R. 2006 . DAART + : Integrating HIV treatment adherence and prevention. Paper presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . March 2006 , New Jersey, USA.
  • Mocroft , A. , Youle , M. , Moore , A. , Sabin , C. A. , Madge , S. Cozzi , A. Lepri . 2001 . Reasons for modification and discontinuation of antiretro virais: Results from a single treatment centre . AIDS , 15 : 185 – 194 .
  • Montaner , J. S. G. , Hogg , R. , Wood , E. , Kerr , T. , Tyndall , M. Levy , A. R. 2006 . The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic . Lancet , 368 : 531 – 536 .
  • Mugyenyi , P. 2006 . Advancing HIV treatment and adherence in Africa. Paper presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . March 2006 , New Jersey, USA.
  • NDVIH/IAPAC International Conference on HTV Treatment Adherence Poster Abstracts, Part 1. Journal of the International Association of Physicians in AIDS Care . Vol. 5 , pp. 11 – 28 .
  • Oral Abstracts. NDVIH/IAPAC International Conference on HIV Treatment Adherence. Journal of the International Association of Physicians in AIDS Care . Vol. 5 , pp. 29 – 39 .
  • NDVIH/IAPAC International Conference on HTV Treatment Adherence. Poster Abstracts, Part 2. Journal of the International Association of Physicians in AIDS Care . Vol. 5 , pp. 57 – 82 .
  • Omrani , A. S. and Freedman , A. 2005 . Prophylaxis of HIV Infection . British Medical Bulletin , 73–74 : 93 – 105 .
  • Palacio , H. , Kahn , J. G. , Richards , T. A. and Morin , S. F. 2002 . Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: A review of the literature . Public Health Reports , 117 : 233 – 251 .
  • Paterson , D. L. , Swindells , S. , Mohr , J. , Brester , M. , Vergis , E. N. Squier , C. 2000 . Adherence to protease inhibitor therapy and outcomes in patients with HIV infection . Annals of Internal Medicine , 133 : 21 – 30 .
  • Peretti-Watel , P. , Spire , B. , Pierret , J. , Lert , F. , Obadia , Y. and the VESPA Group . 2006 . Management of HIV-related stigma and adherence to HAART: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003) . AIDS Care , 18 : 254 – 261 .
  • Reif , S. , Whetten , K. , Lowe , K. and Ostermann , J. 2006 . Association of unmet needs for support services with medication use and adherence among HrV-infected individuals in the southeastern United States . AIDS Care , 18 : 277 – 283 .
  • Remien , R. H. , Stirratt , M. J. and Dognin , J. S. 2006 . Couple-based adherence intervention: How-to. Workshop presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . March 2006 , New Jersey, USA.
  • Rintamaki , L. S. , Davis , T. C. , Skripkauskas , S. , Bennett , C. L. and Wolf , M. S. 2006 . Social stigma concerns and HIV medication adherence . AIDS Patient Care and STDs , 20 : 359 – 368 .
  • Sarna , A. , Luchters , S. , Geibel , S. , Kaai , S. , Munyao , P. Mandaliya , K. 2006 . A randomized controlled trial evaluating a directly administered antiretroviral therapy (DAART) intervention to promote adherence to ART in Mombasa, Kenya. Presented at the NDVIH/IAPAC 1 st International Conference on HIV Treatment Adherence, Newark . March 2006 , New Jersey, USA.
  • Simoni , J. M. , Pearson , C. R. , Pantalone , D. W. , Crepaz , N. and Marks , G. 2006 . State of the ART: Interventions. Paper presented at the 1st International Conference on HIV Treatment Adherence, Jersey City . March 2006 , New Jersey, USA.
  • Stirratt , M. J. , Remien , R. H. , Smith , A. , Copeland , O. Q. , Dolezal , C. , Krieger , D. and the SMART Couples Study Team . 2006 . The role of HIV serostatus disclosure in antiretro viral medication adherence . AIDS and Behavior , 10 : 483 – 493 .
  • Stone , V. E. 2004 . Optimizing the care of minority patients with HIV/AIDS . Clinical Infectious Diseases , 38 : 400 – 404 .
  • Touloumi , G. , Pantazis , N. , Antoniou , A. , Stirnadel , H. A. , Walker , S. A. Porter , K. 2006 . Highly active antiretro viral therapy interruption: Predictors and virologie and immunologie consequences . Journal of Acquired Immune Deficiency Syndromes , 42 : 554 – 561 .
  • Valdiserri , R. O. 2004 . International scale-up for antiretro viral treatment: Where does prevention fit? . Journal of Acquired Immune Deficiency Syndromes , 37 ( Suppl. 2 ) : S138 – S141 .
  • Velasco-Hernandez , J. X. , Gershengorn , H. B. and Blower , S. M. 2002 . Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? . Lancet Infectious Diseases , 2 : 487 – 493 .
  • Weiser , S. , Wolfe , W. , Bangsberg , D. , Thior , I. , Gilbert , P. Makhema , J. 2003 . Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana . Journal of Acquired Immune Deficiency Syndromes , 34 : 281 – 288 .
  • Youle , M. and Wainberg , M. A. 2003 . Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy . Journal of the International Association of Physicians in AIDS Care , 2 : 102 – 105 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.